Chemed Corp (CHE)

Currency in USD
539.72
-0.85(-0.16%)
Closed·
539.720.00(0.00%)
·
Advertisement
CHE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
531.01543.50
52 wk Range
365.21551.68
Key Statistics
Prev. Close
539.72
Open
532.15
Day's Range
531.01-543.5
52 wk Range
365.21-551.68
Volume
247.68K
Average Volume (3m)
201.56K
1-Year Change
26.0792%
Book Value / Share
62.83
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CHE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
552.00
Upside
+2.28%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Chemed Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
3 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 552.00
(+2.28% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Oppenheimer
Buy590.00+9.32%500.00Maintain31/07/2026
RBC Capital
Hold548.00+1.53%436.00Maintain30/07/2026
BofA Securities
Hold550.00+1.90%510.00Maintain29/07/2026
Jefferies
Hold520.00-3.65%450.00Maintain29/07/2026
RBC Capital
Hold436.00-19.22%422.00Maintain27/04/2026

Chemed Corp Earnings Call Summary for Q2/2026

  • Chemed Q2 adjusted EPS of $6.06 beat estimates by $0.46, up 41.9% YoY; revenue rose 8.8% to $673.25M, topping forecasts by $8.21M.
  • VITAS hospice unit drove growth with revenue up 11.9% to $443.3M; admissions rose 9% and patient census exceeded 24,000 for first time.
  • Company raised full-year VITAS guidance: revenue growth now 8.25%-9.25% vs. 6.5%-7.5%; EBITDA margin lifted to 19%-19.5% from 18%-18.5%.
  • Medicare Cap billing limitation for VITAS cut to $7M from $9.5M; no cap expected for Florida program in 2026 vs. $16.4M charge in Q2 2025.
  • Roto-Rooter guidance unchanged despite margin pressure from rising paid lead costs, now 59% of total vs. 44% 1.5 years ago; shares rose 4.33%.
Last Updated: 29/07/2026, 16:08
Read Full Transcript

Earnings

Latest Release
28/07/2026
EPS / Forecast
6.06 / 5.60
Revenue / Forecast
673.25M / 665.04M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 19.91%
Dividend Yield
0.44%
Industry Median 2.03%
Annualised payout
2.40
Paid quarterly
5-Years Growth
+12.03%
Growth Streak

Chemed (CHE) Income Statement & Profits

Compare CHE to Peers and Sector

Metrics to compare
CHE
Peers
Sector
Relationship
P/E Ratio
25.5x18.5x−0.4x
PEG Ratio
11.523.550.00
Price/Book
8.5x3.9x2.6x
Price / LTM Sales
2.7x1.3x3.0x
Upside (Analyst Target)
1.6%20.7%51.9%
Fair Value Upside
Unlock7.6%7.2%Unlock

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
6.93M52.43%3.75B
Other Institutional Investors
6.90M47.57%3.73B
Public Companies & Retail Investors
0.000.00%0.00
Total
13.83M100.00%7.48B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.10.11%1,336,690722,575
Vanguard Portfolio Management, LLC6.17%815,699440,942

People Also Watch

141.67
Q
+6.28%
13.68
AVTR
+0.07%
287.60
ONTO
+7.12%
154.75
CHRW
+5.27%

FAQ

What Is the Chemed (NYSE: CHE) Share Price Today?

The Chemed stock price today is 539.72 USD.

What Stock Exchange Does Chemed (CHE) Trade On?

Chemed is listed and trades on the New York Stock Exchange.

What Is the Ticker (Stock Symbol) for Chemed?

The stock symbol (also called a 'ticker') for Chemed is "CHE."

Does Chemed Pay Dividends? What’s The Current CHE Dividend Yield?

Yes, CHE Pays Dividends to its Shareholders. The current Chemed dividend yield is 0.44%.

What Is the Current Chemed Market Capitalisation?

As of today, Chemed (NYSE: CHE) market cap is 7.02B USD.

What Is Chemed's (CHE) Earnings Per Share (TTM)?

The Chemed EPS is currently 19.91 (Trailing Twelve Months).

When Is the Next Chemed Earnings Date?

Chemed's next earnings report will be released on 03/11/2026.

Is CHE a Buy or Sell From a Technical Analyst Perspective?

Based on today's Chemed moving averages and other technical indicators, the daily buy/sell signal for CHE stock is Strong Buy.

How Many Times Has Chemed Stock Split?

Chemed has split 2 times. (See the CHE stock split history page for full effective split date and price information.)

How Many Employees Does Chemed Have?

Chemed has 15811 employees, based on their latest Companies House report.

What is the current trading status of Chemed (NYSE: CHE)?

As of 05/08/2026, Chemed (CHE) is trading at a share price of 539.72 USD, with a previous close of 539.72 USD. The stock has fluctuated within a day range of 531.01 USD to 543.50 USD, while its 52-week range spans from 365.21 USD to 551.68 USD.

What Is Chemed (CHE) Price Target According to Analysts?

The average 12-month price target for Chemed is 552.00 USD, with a high estimate of 590 USD and a low estimate of 520 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +2.28% Upside potential.

What Is the CHE Premarket Price?

CHE's last pre-market stock price is 547.00 USD. The pre-market share volume is 20.00, and the stock has decreased by 6.43, or 1.19%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.